Neuroprotection mediated by the EP₄ receptor avoids the detrimental side effects of COX-2 inhibitors following ischaemic injury.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Neuropharmacology

• Publication date

  2013-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.neuropharm.2012.09.010PMID 23041537
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of the EP receptor types that mediate longitudinal smooth muscle contraction of human colon, mouse colon and mouse ileum

  2011cited by this paper
• Signaling via the prostaglandin E₂ receptor EP4 exerts neuronal and vascular protection in a mouse model of cerebral ischemia.

  2011influential reference
• The COXIB experience: a look in the rearview mirror.

  2009cited by this paper
• The ischemic cascade and mediators of ischemic injury.

  2009cited by this paper
• The Neuroprotective Effect of Prostaglandin E2 EP1 Receptor Inhibition has a Wide Therapeutic Window, is Sustained in Time and is not Sexually Dimorphic

  2009cited by this paper
• Reduced acute brain injury in PGE2 EP3 receptor-deficient mice after cerebral ischemia.

  2009cited by this paper
• Mechanisms of ischemic brain damage.

  2008influential reference
• Effects of EP1 receptor on cerebral blood flow in the middle cerebral artery occlusion model of stroke in mice

  2007cited by this paper
• Clinical practice. Acute ischemic stroke.

  2007cited by this paper
• Stimulation of prostaglandin E2-EP3 receptors exacerbates stroke and excitotoxic injury.

  2007cited by this paper
• Cyclooxygenase-2 Does Not Contribute to Postischemic Production of Reactive Oxygen Species

  2007cited by this paper
• Targeting PGE2 receptor subtypes rather than cyclooxygenases: a bridge over troubled water?

  2006cited by this paper
• Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity

  2006cited by this paper
• GW627368X ((N‐{2‐[4‐(4,9‐diethoxy‐1‐oxo‐1,3‐dihydro‐2H‐benzo[f]isoindol‐2‐yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist

  2006influential reference
• Prostaglandin E2 deteriorates N-methyl-D-aspartate receptor-mediated cytotoxicity possibly by activating EP2 receptors in cultured cortical neurons.

  2006cited by this paper
• Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage.

  2006cited by this paper
• Preparation of organotypic hippocampal slice cultures: interface method

  2006cited by this paper
• The dual role of prostaglandin E(2) in excitotoxicity and preconditioning-induced neuroprotection.

  2005cited by this paper
• The Janus Face of Cyclooxygenase-2 in Ischemic Stroke: Shifting Toward Downstream Targets

  2005influential reference
• Prostaglandin EP4 receptor agonist protects against acute neurotoxicity.

  2005influential reference
• Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia

  2005cited by this paper
• Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.

  2005cited by this paper
• Neuroprotective Function of the PGE2 EP2 Receptor in Cerebral Ischemia

  2004influential reference
• An optimized triphenyltetrazolium chloride method for identification of cerebral infarcts.

  2004cited by this paper
• Failing the public health--rofecoxib, Merck, and the FDA.

  2004influential reference
• Progesterone Enhances Functional Recovery after Middle Cerebral Artery Occlusion in Male Mice

  2004cited by this paper
• Prostaglandin E2 induced caspase-dependent apoptosis possibly through activation of EP2 receptors in cultured hippocampal neurons.

  2004cited by this paper
• Discovery and Synthesis of a Potent, Selective and Orally Bioavailable EP4 Receptor Agonist

  2004cited by this paper
• EP2 and EP4 prostanoid receptor signaling.

  2003cited by this paper
• Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice.

  2001influential reference
• Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

  2000cited by this paper
• Cognitive deficits after focal cerebral ischemia in mice.

  2000cited by this paper
• Expression of nitric oxide synthase (NOS)-2 following permanent focal ischemia and the role of nitric oxide in infarct generation in male, female and NOS-2 gene-deficient mice.

  1999cited by this paper
• Citicoline treatment for experimental intracerebral hemorrhage in mice.

  1998cited by this paper
• Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat.

  1997cited by this paper
• Cyclo-Oxygenase-2 Gene Expression in Neurons Contributes to Ischemic Brain Damage

  1997cited by this paper
• Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.

  1994cited by this paper
• A simple method for organotypic cultures of nervous tissue.

  1991cited by this paper
• A simple method for organotypic cultures of nervous tissue

  1991cited by this paper

• The Enhanced Cytotoxic Effects in B-Cell Leukemia and Lymphoma Following Activation of Prostaglandin EP4 Receptor and Targeting of CD20 Antigen by Monoclonal Antibodies

  2022cites this paper
• Inducible Prostaglandin E Synthase as a Pharmacological Target for Ischemic Stroke

  2022cites this paper
• MOP and NOP receptor interaction: Studies with a dual expression system and bivalent peptide ligands

  2022cites this paper
• Neuroprotective and cerebrovascular effects of endogenous N-Arachidonoyl-GABA and its putative Cox-2 metabolite – GABA conjugate with Prostaglandin E2

  2021cites this paper
• Neuroprotective effects of Ginkgolide B in focal cerebral ischemia through selective activation of prostaglandin E2 receptor EP4 and the downstream transactivation of epidermal growth factor receptor

  2021cites this paper
• Sexual dimorphism following in vitro ischemia in the response to neurosteroids and mechanisms of injury

  2020cites this paper
• Gadolinium-based neuroprognostic magnetic resonance imaging agents suppress COX-2 for prevention of reperfusion injury after stroke.

  2020cites this paper
• EP4 receptor agonist L-902688 augments cytotoxic activities of ibrutinib, idelalisib, and venetoclax against chronic lymphocytic leukemia cells.

  2020cites this paper
• Small molecules targeting cyclooxygenase/prostanoid cascade in experimental brain ischemia: Do they translate?

  2020cites this paper
• Prostaglandin E receptors as targets for ischemic stroke: novel evidence and molecular mechanisms of efficacy.

  2020influential citation
• International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1–4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions

  2020cites this paper
• The Effects of Celecoxib on Rotenone-Induced Rat Model of Parkinson’s Disease: Suppression of Neuroinflammation and Oxidative Stress-Mediated Apoptosis

  2019cites this paper
• The impact of age on the elicitation of spreading depolarization and the implication of prostanoids in the associated cerebral blood flow response

  2019cites this paper
• Difluoromethylene at the γ-Lactam α-Position Improves 11-Deoxy-8-aza-PGE1 Series EP4 Receptor Binding and Activity: 11-Deoxy-10,10-difluoro-8-aza-PGE1 Analog (KMN-159) as a Potent EP4 Agonist.

  2019cites this paper
• Protective Effects of L-902,688, a Prostanoid EP4 Receptor Agonist, against Acute Blood-Brain Barrier Damage in Experimental Ischemic Stroke

  2018cites this paper
• Prostaglandin E2 EP4 Receptor Activation Attenuates Neuroinflammation and Early Brain Injury Induced by Subarachnoid Hemorrhage in Rats

  2017cites this paper
• Contribution of prostanoid signaling to the evolution of spreading depolarization and the associated cerebral blood flow response

  2016cites this paper
• Title Prostaglandin E Receptor Subtype 4 Signaling in the Heart: Role in Ischemia/Reperfusion Injury and Cardiac Hypertrophy

  2016cites this paper
• Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke.

  2016cites this paper
• RECENT DEVELOPMENT IN COX-2 INHIBITORS SYNTHESIS AND THEIR PHARMACOLOGICAL EVALUATION: A REWIEV

  2016cites this paper
• The Coxib case: Are EP receptors really guilty?

  2016cites this paper
• Prostaglandin E Receptor Subtype 4 Signaling in the Heart: Role in Ischemia/Reperfusion Injury and Cardiac Hypertrophy

  2016cites this paper
• An EP2 Agonist Facilitates NMDA-Induced Outward Currents and Inhibits Dendritic Beading through Activation of BK Channels in Mouse Cortical Neurons

  2016cites this paper
• Development and elucidation of mechanism of action of new leads to attenuate neuroinflammation in stroke model.

  2015cites this paper
• Determining the role of NMDA receptors and ATP receptors in the pathological damage following stroke

  2015cites this paper
• The effect of cilostazol and aspirin pre-treatment against subsequent transient focal cerebral ischemia in rat

  2014cites this paper
• Cyclooxygenase 2 inhibitor celecoxib inhibits glutamate release by attenuating the PGE2/EP2 pathway in rat cerebral cortex endings

  2014cites this paper
• Inflammation in ischemic stroke: mechanisms, consequences and possible drug targets.

  2014cites this paper
• Time course change of COX2-PGI2/TXA2 following global cerebral ischemia reperfusion injury in rat hippocampus

  2014cites this paper
• Cyclooxygenase 2 Inhibitor Celecoxib Inhibits Glutamate Release by Attenuating the PGE2/EP2 Pathway in Rat Cerebral Cortex Endings

  2014cites this paper
• Examining the potential of PGE₂ receptor EP₄ as a neuroprotective target following ischaemic injury

  2013cites this paper
• Apobec-1 Increases Cyclooxygenase-2 and Aggravates Injury in Oxygen-Deprived Neurogenic Cells and Middle Cerebral Artery Occlusion Rats

  2013cites this paper